Abstract
BackgroundNumerous host cellular factors are exploited by viruses to facilitate infection. Our previous studies and those of others have shown heat-shock protein 90 (Hsp90), a cellular molecular chaperone, is involved in herpes simplex virus (HSV)-1 infection. However, the function of the dominant Hsp90 isoform and the relationship between Hsp90 and HSV-1 α genes remain unclear.Methods and resultsHsp90α knockdown or inhibition significantly inhibited the promoter activity of HSV-1 α genes and downregulated virion protein 16(VP16) expression from virus and plasmids. The Hsp90α knockdown-induced suppression of α genes promoter activity and downregulation of α genes was reversed by VP16 overexpression, indicating that Hsp90α is involved in VP16-mediated transcription of HSV-1 α genes. Co-immunoprecipitation experiments indicated that VP16 interacted with Hsp90α through the conserved core domain within VP16. Based on using autophagy inhibitors and the presence of Hsp90 inhibitors in ATG7−/− (autophagy-deficient) cells, Hsp90 inhibition-induced degradation of VP16 is dependent on macroautophagy-mediated degradation but not chaperone-mediated autophagy (CMA) pathway. In vivo studies demonstrated that treatment with gels containing Hsp90 inhibitor effectively reduced the level of VP16 and α genes, which may contribute to the amelioration of the skin lesions in an HSV-1 infection mediated zosteriform model.ConclusionOur study provides new insights into the mechanisms by which Hsp90α facilitates the transactivation of HSV-1 α genes and viral infection, and highlights the importance of developing selective inhibitors targeting the interaction between Hsp90α and VP16 to reduce toxicity, a major challenge in the clinical use of Hsp90 inhibitors.
Highlights
Numerous host cellular factors are exploited by viruses to facilitate infection
Our study provides new insights into the mechanisms by which Hsp90α facilitates the transactivation of herpes simplex virus (HSV)-1 α genes and viral infection, and highlights the importance of developing selective inhibitors targeting the interaction between Hsp90α and virion protein 16 (VP16) to reduce toxicity, a major challenge in the clinical use of heat-shock protein 90 (Hsp90) inhibitors
Hsp90α is involved in modulating the promoter activity of HSV-1 α genes Our previous studies showed that Hsp90 inhibition greatly attenuates HSV-1 infection and the expression of HSV-1 α genes (Xiang et al, 2012a; Zhong et al, 2014)
Summary
Our previous studies and those of others have shown heat-shock protein 90 (Hsp90), a cellular molecular chaperone, is involved in herpes simplex virus (HSV)-1 infection. Hsp has four major isoforms, Hsp90α, Hsp90β, tumor necrosis factor receptor-associated protein 1, and 94-kDa glucose-regulated protein (GRP94) (Whitesell & Lindquist, 2005). The majority of viruses, such as EV71, HIV-1, and hepatitis B virus (HBV), utilize these two isoforms (Burch & Weller, 2005; Whitesell & Lindquist, 2005; Wang et al, 2013; Reyes-Del Valle et al, 2005; Voss et al, 2000). GRP94 can be utilized by hepatitis C virus to inhibit the host immune system response and block viral-induced apoptosis (Song et al, 2008)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.